Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001755695 | SCV002005311 | uncertain significance | not provided | 2024-11-20 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002540704 | SCV003737445 | uncertain significance | Inborn genetic diseases | 2022-01-05 | criteria provided, single submitter | clinical testing | The c.8765G>A (p.S2922N) alteration is located in exon 56 (coding exon 56) of the CUBN gene. This alteration results from a G to A substitution at nucleotide position 8765, causing the serine (S) at amino acid position 2922 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005038313 | SCV005670362 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2024-01-05 | criteria provided, single submitter | clinical testing |